Oskari Sundholm

Title: Oskari Sundholm: Innovator in Enzymatic Synthesis

Introduction

Oskari Sundholm is a notable inventor based in Turku, Finland. He has made significant contributions to the field of enzymatic synthesis, particularly in the pharmaceutical industry. His innovative approach has led to advancements in the preparation of important chemical compounds.

Latest Patents

Oskari Sundholm holds a patent for the "Chiral resolution of an intermediate in diltiazem synthesis using lipase." This patent describes an enzymatic method for the preparation of (2S,3S)-threo-alkyl-2-hydroxy-3-(4-methoxyphenyl)-3-(2-X-phenylthio)propionate. The method utilizes a lipase that stereospecifically acylates the (2R,3R)-enantiomer of a racemic mixture. Following the enzymatic reaction, the (2S,3S)-enantiomer and the acylated (2R,3R)-compound are separated through techniques such as flash-chromatography or fraction crystallization.

Career Highlights

Oskari Sundholm is associated with Orion-Yhtyma Oy Fermion, where he applies his expertise in enzymatic processes. His work has been instrumental in enhancing the efficiency and effectiveness of pharmaceutical synthesis.

Collaborations

Throughout his career, Oskari has collaborated with esteemed colleagues, including Liisa Kanerva and Pekka Kairisalo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Oskari Sundholm's contributions to enzymatic synthesis exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and collaborative efforts highlight the importance of teamwork in advancing scientific knowledge and technology.